Tema ETFs’s ArriVent BioPharma AVBP Stock Holding History

Tema ETFs’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.1M	Sell	36,186 -20,848	-37%	-$639K	0.04%	279
2026 Q2	$1.98M	Buy	+57,034	New	+$1.68M	0.06%	187
2026 Q1	–	Sell	-32,007	Closed	-$644K	–	589
2025 Q4	$644K	Buy	+32,007	New	+$666K	0.05%	312

Other funds holding AVBP

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Tema ETFs's AVBP Position: Q3 2026 in Review

Tema ETFs reduced its ArriVent BioPharma (AVBP) stake by 37% in Q3 2026, selling an estimated $639K and leaving 36,186 shares worth $1.1M. The position accounts for 0.04% of the portfolio, ranked #279.

Tema ETFs first reported a position in AVBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.98M in Q2 2026. 7 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

Tema ETFs held 36,186 shares of ArriVent BioPharma worth $1.1M as of Q3 2026.
Tema ETFs sold 20,848 ArriVent BioPharma shares in Q3 2026, an estimated $639K.
ArriVent BioPharma made up 0.04% of Tema ETFs's portfolio in Q3 2026, its #279 holding.
Tema ETFs first reported a position in ArriVent BioPharma in Q4 2025 and has held it in 3 quarters since.
Tema ETFs's ArriVent BioPharma position peaked at $1.98M in Q2 2026.
7 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.